Malley Thomas — SEC Form 4 filings
SEC reporting owner CIK 1403322. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-04.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-07 to 2026-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 177,769 shares, $5,859,815 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
- Largest priced transaction: sale of 78,233 shares @ $33.09 ($2,588,730) in Kiniksa Pharmaceuticals International, plc, filed 2025-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Director | 4 | — | 3 legs · 177,769 sh · $5,859,815 | 26 |
| Kura Oncology, Inc. (KURA) | Director | 4 | — | — | 5 |
Form 4 filings — Malley Thomas
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,799 · Grant/award (A): 12,158 (derivative) @ $0 · Grant/award (A): 2,026 (derivative) @ $0 · Option exercise (M): 2,799 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Kura Oncology, Inc. (KURA) | Option exercise (M): 10,000 @ $3.12 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 21,959 @ $1.86 · Option exercise (M): 27,448 @ $3.80 · Sale (S): 49,407 @ $32.40 · Option exercise (M): 20,129 @ $10.36 · Option exercise (M): 30,000 @ $9.88 · Sale (S): 50,129 @ $33.32 · +11 more | EDGAR |
| 2025-06-06 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 3,173 · Grant/award (A): 16,798 (derivative) @ $0 · Grant/award (A): 2,799 (derivative) @ $0 · Option exercise (M): 3,173 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 4,373 · Grant/award (A): 19,040 (derivative) @ $0 · Grant/award (A): 3,173 (derivative) @ $0 · Option exercise (M): 4,373 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1403322 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →